Liver PEPCK is a rate-limiting enzyme for gluconeogenesis, a contributing factor in hyperglycemia of Type-II diabetes[34], in which insulin resistance prevents the normal dominant down-regulation by insulin of PEPCK expression[54]. The gene discussed is PCK2; the disease is type 2 diabetes mellitus.